VitroScan develops personalized diagnostics for cancer patients. The tests are based on drug sensitivity screen on 3D tumor tissue cultured directly from patient. For more information on the technology plate visit www.OcellO.nl. For more information on VitroScan please contact us, or revisit the website at a later time.


ovarian cancer patient 1 control
Patient 1 control
ovarian cancer patient 1 3ug/ml Cisplatin
Patient 1 3μg/ml Cispt
ovarian cancer patient 1 5uM olap
Patient 1 5μM Olap
ovarian cancer patient 1 3ugml cispt + olap
Patient 1 3μg/ml Cispt + Olap
Cisplatin sensitive
ovarian cancer patient 2 control
Patient 2 control
ovarian cancer patient 2 100ng/ml cisplatin
Patient 2 100ng/ml Cispt
ovariance cancer patient 2 5um olap
Patient 2 5μM Olap
ovarian cancer patient 2 100ng/ml cisplatin + olap
Patient 2 100ng/ml Cispt + Olap
Cisplatin + Olaparib sensitive
ovarian cancer Patient 3 Control
Patient 3 control
ovarian cancer patient 3 3ug/ml cisplatin
Patient 3 3μg/ml Cispt
ovarian cancer patient 3 5uM olaparib
Patient 3 5μM Olap
ovarian cancer patient 3 3ug/ml cisplatin + olaparib
Patient 3 3μg/ml Cispt + Olap
Olaparib sensitive